178 related articles for article (PubMed ID: 27919202)
21. Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis.
Levitova A; Hulejova H; Spiritovic M; Pavelka K; Senolt L; Husakova M
Arthritis Res Ther; 2016 Nov; 18(1):275. PubMed ID: 27887637
[TBL] [Abstract][Full Text] [Related]
22. Tumor Necrosis Factor-α Inhibition in Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Treatment Response, Drug Survival, and Patient Outcome.
Corli J; Flipo RM; Philippe P; Bera-Louville A; Béhal H; Wibaux C; Paccou J
J Rheumatol; 2015 Dec; 42(12):2376-82. PubMed ID: 26568593
[TBL] [Abstract][Full Text] [Related]
23. Fibromyalgia in Spondyloarthritis: Effect on Disease Activity Assessment in Clinical Practice.
Wach J; Letroublon MC; Coury F; Tebib JG
J Rheumatol; 2016 Nov; 43(11):2056-2063. PubMed ID: 27633820
[TBL] [Abstract][Full Text] [Related]
24. Alcohol consumption as a predictor of the progression of spinal structural damage in axial spondyloarthritis: data from the Catholic Axial Spondyloarthritis COhort (CASCO).
Min HK; Lee J; Ju JH; Park SH; Kwok SK
Arthritis Res Ther; 2019 Aug; 21(1):187. PubMed ID: 31412929
[TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics of non-radiographic axial spondyloarthritis: Results of the Korean Nonradiographic Axial SPondyloArthritis (KONASPA) data.
Jeong H; Kim YG; Kim TH; Kim TJ; Park MC; Seo MR; Shin K; Oh JS; Lee SH; Lee YA; Lee EY; Baek HJ; Cha HS
Int J Rheum Dis; 2021 Sep; 24(9):1137-1147. PubMed ID: 34250745
[TBL] [Abstract][Full Text] [Related]
26. Elevated serum level of the vascular endothelial growth factor predicts radiographic spinal progression in patients with axial spondyloarthritis.
Poddubnyy D; Conrad K; Haibel H; Syrbe U; Appel H; Braun J; Rudwaleit M; Sieper J
Ann Rheum Dis; 2014 Dec; 73(12):2137-43. PubMed ID: 23956246
[TBL] [Abstract][Full Text] [Related]
27. The impact of sex and disease classification on patient-reported outcome measures in axial spondyloarthritis: a descriptive prospective cross-sectional study.
Andreasen RA; Kristensen LE; Egstrup K; Baraliakos X; Strand V; Horn HC; Hansen IMJ; Christensen R; Ellingsen T
Arthritis Res Ther; 2019 Oct; 21(1):221. PubMed ID: 31665083
[TBL] [Abstract][Full Text] [Related]
28. Fatigue in Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Analysis from a Longitudinal Observation Cohort.
Bedaiwi M; Sari I; Thavaneswaran A; Ayearst R; Haroon N; Inman RD
J Rheumatol; 2015 Dec; 42(12):2354-60. PubMed ID: 26523020
[TBL] [Abstract][Full Text] [Related]
29. Central Obesity in Axial Spondyloarthritis: The Missing Link to Understanding Worse Outcomes in Women?
Maguire S; Wilson F; Gallagher P; O'Shea F
J Rheumatol; 2022 Jun; 49(6):577-584. PubMed ID: 35232810
[TBL] [Abstract][Full Text] [Related]
30. Preliminary definitions of 'flare' in axial spondyloarthritis, based on pain, BASDAI and ASDAS-CRP: an ASAS initiative.
Gossec L; Portier A; Landewé R; Etcheto A; Navarro-Compán V; Kroon F; van der Heijde D; Dougados M
Ann Rheum Dis; 2016 Jun; 75(6):991-6. PubMed ID: 26847821
[TBL] [Abstract][Full Text] [Related]
31. Obesity Increases Disease Activity of Norwegian Patients with Axial Spondyloarthritis: Results from the European Map of Axial Spondyloarthritis Survey.
Bindesbøll C; Garrido-Cumbrera M; Bakland G; Dagfinrud H
Curr Rheumatol Rep; 2020 Jun; 22(8):43. PubMed ID: 32577833
[TBL] [Abstract][Full Text] [Related]
32. Metabolites of C-reactive protein and vimentin are associated with disease activity of axial spondyloarthritis.
Siebuhr AS; Hušaková M; Forejtová S; Zegzulková K; Tomčik M; Urbanová M; Grobelná K; Gatterová J; Bay-Jensen AC; Pavelka K
Clin Exp Rheumatol; 2019; 37(3):358-366. PubMed ID: 30767876
[TBL] [Abstract][Full Text] [Related]
33. Ankylosing spondylitis and nonradiographic axial spondyloarthritis: part of a common spectrum or distinct diseases?
Wallis D; Haroon N; Ayearst R; Carty A; Inman RD
J Rheumatol; 2013 Dec; 40(12):2038-41. PubMed ID: 24187102
[TBL] [Abstract][Full Text] [Related]
34. Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers.
Gentileschi S; Vitale A; Rigante D; Lopalco G; Emmi G; Orlando I; Di Scala G; Sota J; Fabiani C; Frediani B; Galeazzi M; Lapadula G; Iannone F; Cantarini L
Isr Med Assoc J; 2018 Jul; 20(7):438-441. PubMed ID: 30109794
[TBL] [Abstract][Full Text] [Related]
35. Disease activity is longitudinally related to sacroiliac inflammation on MRI in male patients with axial spondyloarthritis: 2-years of the DESIR cohort.
Navarro-Compán V; Ramiro S; Landewé R; Dougados M; Miceli-Richard C; Richette P; van der Heijde D
Ann Rheum Dis; 2016 May; 75(5):874-8. PubMed ID: 26403689
[TBL] [Abstract][Full Text] [Related]
36. Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort.
Ramiro S; van der Heijde D; van Tubergen A; Stolwijk C; Dougados M; van den Bosch F; Landewé R
Ann Rheum Dis; 2014 Aug; 73(8):1455-61. PubMed ID: 24812292
[TBL] [Abstract][Full Text] [Related]
37. Anti-CD74 IgA autoantibodies in radiographic axial spondyloarthritis: a longitudinal Swedish study.
Do L; Granåsen G; Hellman U; Lejon K; Geijer M; Baraliakos X; Witte T; Forsblad-d'Elia H
Rheumatology (Oxford); 2021 Sep; 60(9):4085-4093. PubMed ID: 33369649
[TBL] [Abstract][Full Text] [Related]
38. Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine.
Landewé R; Dougados M; Mielants H; van der Tempel H; van der Heijde D
Ann Rheum Dis; 2009 Jun; 68(6):863-7. PubMed ID: 18628283
[TBL] [Abstract][Full Text] [Related]
39. Performance of the Ankylosing Spondylitis Disease Activity Score based on a quick quantitative C-reactive protein assay in patients with axial spondyloarthritis.
Proft F; Muche B; Spiller L; Rios Rodriguez V; Rademacher J; Weber AK; Lüders S; Protopopov M; Redeker I; Spiller I; Sieper J; Poddubnyy D
Joint Bone Spine; 2020 Jan; 87(1):69-73. PubMed ID: 31369867
[TBL] [Abstract][Full Text] [Related]
40. The predictability of ASDAS on drug survival in patients with ankylosing spondylitis on biologic therapy: data from the KOBIO registry.
Kim J; Kim MJ; Oh GY; Lee SK; Kim T; Shin K
Ther Adv Musculoskelet Dis; 2023; 15():1759720X231201714. PubMed ID: 37822329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
